Iloprost Pretreatment Before Unilateral Nephrectomy: An Experimental Study in Rats  by Aytac, Erman et al.
ASIAN JOURNAL OF SURGERY VOL 31 • NO 2 • APRIL 2008 69
Iloprost Pretreatment Before Unilateral
Nephrectomy: An Experimental Study in Rats
Erman Aytac,1 Pinar Seymen,2 Goksel Dikmen,3 Hafize Uzun4 and Hakki Oktay Seymen,5 Departments of 
1General Surgery, 4Biochemistry and 5Physiology, Cerrahpasa Medical Faculty, and 3Department of Orthopedics,
Istanbul Medical Faculty, Istanbul University, and 2Division of Nephrology, Department of Internal Medicine,
Haydarpasa Numune Research and Training Hospital, Istanbul, Turkey.
OBJECTIVE: To evaluate the effects of iloprost administration before unilateral nephrectomy on 
postoperative interleukin-6 (IL-6), nitric oxide (NO), and oxidant/antioxidant status.
METHODS: Malondialdehyde, glutathione, catalase and Cu-Zn superoxide dismutase were measured in
the blood and remnant kidney of Adult male Wistar albino rats to asses oxidant and antioxidant status.
The rats were divided into three experimental groups: sham group (S) (n = 12); unilateral nephrectomized
group (N) (n = 12); an hour before unilateral nephrectomy iloprost (1 ng/mL/kg, intraperitoneal) admin-
istered group (IN) (n = 12).
RESULTS: Iloprost administration before unilateral nephrectomy lowered oxidant parameters and IL-6
levels significantly. NO levels were increased in both N and IN groups.
CONCLUSION: Iloprost pretreatment before unilateral nephrectomy can reduce oxidative stress and
IL-6, which increases due to anaesthesia and surgery and causes organ damage during surgery and in the
short-term postoperative period. [Asian J Surg 2008;31(2):69–74]
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Introduction
Many drugs and different techniques are being examined
to reduce organ damage due to surgery and to inhibit the
stress responses to surgical procedures.1,2 As an example,
in abdominal aortic surgery, the effects of intravenous 
N-acetylcysteine for the prevention of renal injury in patients
with no previously documented renal dysfunction was eval-
uated and it was found that it did not offer any significant
protection from renal injury during elective aortic operation
in patients with normal preoperative renal function.3
Iloprost is a chemically stable derivative of a naturally-
occurring prostacyclin. Prostacyclin, which is derived from
the endothelium, is a potent vasodilator. Prostacyclin has
antithrombotic effects and inhibits activation of neutrophil
leucocytes, activates fibrinolysis and impairs erythrocyte
flexibility.4 Several studies have demonstrated protective
effects of iloprost.1
Unilateral nephrectomy is a surgical procedure that is
performed for the treatment of many kidney pathologies,
such as renal tumours and trauma or for living kidney
donation. Preservation of functional kidney tissue is impor-
tant for the maintenance of homeostasis.5 Unilateral ne-
phrectomy could be risky for metabolism and especially for
the remaining kidney which has to adapt to the new con-
ditions after unilateral nephrectomy.6 Removal of one
kidney induces some short- and long-term adaptation
mechanisms that lead to biochemical and physical changes.
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Some hormonal neuronal functions can take place in this
adaptive response.7 During the adaptation period, some
unfavourable consequences can occur. Infection, bleeding
and other postoperative complications can be observed.8
Oxidant and antioxidant status is vital for regulation
of homeostasis. Reactive oxygen species (ROS), namely
superoxide and hydroxyl free radicals, together with hy-
drogen peroxide, are believed to be directly toxic, and ROS
can initiate a free-radical-mediated chain reaction that
causes additional organ damage.9 A number of changes
follow tissue injury stimulated by cytokines, particularly
interleukin-6 (IL-6), which is primarily involved in the
regulation of immune and inflammatory responses.10
It has been demonstrated that plasma IL-6 increases in
surgical stress, which is the name given to the hormonal
and metabolic changes that occur following surgery such
as laparotomy.11 IL-6 which is a fundamental cytokine
function in regulating acute phase response is produced
by activated T and B lymphocytes, monocytes/macro-
phages, endothelial cells, fibroblasts, vascular smooth
muscle cells, endothelial cells and locally at the sites of tis-
sue damage, and induces the hepatic synthesis of acute
phase plasma proteins.10–12 Nitric oxide (NO) can medi-
ate a number of physiological and pathological reac-
tions.13 NO has an important role in kidney function such
as the suppression of smooth muscle cell proliferation,
renal macrovascular and microvascular dilatation, modu-
lation renal medullary blood flow, simulation of fluid, re-
gulation of mitochondrial respiration and electrolyte
balance.6
Increased oxidative stress is one of the important fac-
tors that causes organ dysfunction during surgery and in
the short-term postoperative period.14 We prefer unilat-
eral nephrectomy to induce surgical stress. The kidney is
one of the most sensitive organs whose functions could
diminish due to anaesthesia and surgery. The effects of
iloprost pretreatment in unilateral nephrectomy on oxida-
tive stress and proinflammatory cytokines are unknown.
This study was performed to detect the effects of iloprost
administration before unilateral nephrectomy on postop-
erative oxidative stress, NO and IL-6, which is a proinflam-
matory cytokine. We evaluated if iloprost pretreatment
could reduce the oxidative stress and inflammation that can
cause organ damage during surgery. Whole blood and re-
maining kidney tissue were assed to evaluate systemic and
tissue oxidative stress after unilateral nephrectomy.
Malondialdehyde (MDA), glutathione (GSH) and Cu-Zn
superoxide dismutase (Cu-Zn SOD) were measured in
both blood and remnant kidney. Urea, creatinine and
plasma IL-6 levels were measured only in blood, and cata-
lase and NO levels were measured only in the remaining
kidney.
Methods
This study was performed after approval from the Ethics
Committee of the Animal Care Review Board of Istanbul
University’s Cerrahpasa Medical Faculty, and conducted
according to the Guide for the Care and Use of Laboratory
Animals. Adult male Wistar albino rats obtained from the
Experimental Animal Research and Production Laboratory
of Cerrahpasa Medical Faculty, weighing 200–250 g, were
used. Animals were housed in cages in a regulated envi-
ronment (23 ± 2°C, 55 ± 15% relative humidity) under a
12-hour light/dark cycle (on 8:00 to 20:00), cared for in
accordance with the Guide for the Care and Use of Laboratory
Animals and permitted ad libitum access to standard lab
chow and tap water during all experimental procedures
(Committee on Care and Use of Laboratory Animals.
Guide for the Care and Use of Laboratory Animals. Washington,
DC: Institute of Laboratory Animal Resources, National
Research Council, 1985, page 83). All experiments were
performed at the Cerrahpasa Medical Faculty Experi-
mental Animal Research and Production Laboratory. The
rats were divided into three weight-matched groups:
sham group (S) (n = 12); unilateral nephrectomized group
(N) (n = 12); an hour before unilateral nephrectomy ilo-
prost (1 ng/mL/kg, intraperitoneal) administered group
(IN) (n = 12).
Surgical procedure
The operations were performed in groups of rats between
9 a.m. and 12 p.m. to standardize the effects of diurnal
changes. The left posterior and lateral abdominal wall was
cleansed with batticon solution after shaving. Under ket-
amine chlorohydrate (40 mg/kg, intraperitoneal) anaes-
thesia, left posterior intercostal incision was performed
between the 11th and 12th ribs and the left kidney removed.
In the S group, only posterior incision was performed and
the kidney was not removed. All of the operations were
performed in sterile conditions. The incision was closed
with 2/0 silk continuous sutures as a single layer. The rats
were sacrificed by decapitation, blood samples were col-
lected by intracardiac puncture, and remnant kidneys
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were collected for biochemical analyses after 24 hours
from operation. Remnant kidneys were stored at −70°C
until analysis.
Biochemical procedure
Blood samples were collected in heparinized vacutainer
tubes and immediately transported in a cooler with ice to
the laboratory. Serum urea and creatinine levels were meas-
ured immediately after collection of the blood samples
before plasma separation. On arrival at the laboratory,
plasma was separated by centrifugation (+4°C, 3,000 rpm,
10 min) and divided into 0.5–1.0 mL aliquots, placed in
cryovials and stored at −70°C until analysis.
Assay of serum urea and creatinine
All animals, rat serum urea and creatinine levels were deter-
mined with a commercially available kit (Diasis; Teco
Diagnostics, Anaheim, CA, USA).
Assay of catalase
Catalase activity was measured by the breakdown of hydro-
gen peroxide catalysed by the catalase enzyme.15
Assay of MDA
Lipoperoxidation was ascertained by the formation of
MDA, which was estimated by the modified thiobarbi-
turic acid method, described by Buege and Aust.16 Thio-
barbituric acid-reactive substance (TBARS) concentration
was calculated using 1.56×10−5 M cm−1 as mol/L extinction
coefficient.
Assay of Cu-Zn SOD activity
Cu-Zn SOD activity was determined by the method of Sun
et al.17 The assay involves inhibition of nitroblue tetra-
zolium (NBT) (Sigma Chemical Co., St Louis, MO, USA)
and reduction with xanthine–xanthine oxidase (Sigma
Chemical Co.) that is used as a superoxide generator. One
unit of SOD is defined as the amount of protein that
inhibits the rate of NBT reduction by 50%.
Assay of tissue GSH
Tissue GSH concentration was determined according 
to the method of Beutler et al using metaphosphoric acid
for protein precipitation and 50-50-dithiobis-2-nitroben-
zoic acid for colour development.18 The total protein con-
centration of tissues was measured by the method of
Lowry et al.19
Assay of NO
NO was measured as its stable metabolites nitrate (NO3−)
and nitrite (NO2−). Nitrate was first reduced by nitrate
reductase to nitrite and then nitrite was determined spec-
trophotometrically by the Griess reaction20 (Roche, Cat No
1 756 281). Plasma and tissue NO concentrations were
expressed as µmol/L and µmol/g wet tissue, respectively.
Assay of intraerythrocytic GSH
Reduced GSH concentration was determined according
to the method of Beutler et al using metaphosphoric acid
for protein precipitation and 5-5′-ditiobis-2-nitrobenzoic
acid for colour development.21 Erythrocyte and tissue GSH
concentrations were expressed as mg/g haemoglobin and
mg/g protein in kidney tissue, respectively. Haemoglobin
concentration was determined by the cyanamethaemo-
globin method.22
Measurement of IL-6 by ELISA
Rat serum IL-6 levels were analysed by a commercially
available ELISA kit (R&D Systems, Abingdon, Oxon, UK).
Analyses of all samples, standards and controls were run in
duplicate. The principal methodology for this immunoas-
say was the same for all cytokines. The coefficients of intra-
and interassay variations for IL-6 were 4.6% (n = 7), 7.4%
(n = 7), 4.3% (n = 7) and 7.1% (n = 7), respectively.
Data analysis
The data are presented as mean ± standard deviation. SPSS
version 12.0 (SPSS Inc., Chicago, IL, USA) was used for
statistical analysis. Analysis of variance and independent
samples t test were employed to determine the p values
between groups. The level of statistical significance was
taken as p < 0.05.
Results
The serum urea and creatinine levels, plasma IL-6, MDA
and intraerythrocytic GSH, and SOD levels are summarized
in Table 1. There were no significant differences between the
experimental groups’ serum urea and creatinine levels. N
group serum urea and creatinine levels were increased but
were not significant. N group plasma IL-6 levels were signif-
icantly higher than S group levels (p < 0.001). IN group
plasma IL-6 levels were significantly lower than N group
levels (p <0.05). There was no significant difference between
S and IN groups’ plasma IL-6 levels. The plasma MDA levels
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in the N group were significantly higher than in the S
group. IN group MDA levels were significantly lower than
N group levels. Intraerythrocytic GSH levels in the N group
were significantly lower than in the S and IN groups. There
were no significant differences between the experimental
groups’ intraerythrocytic Cu-Zn SOD levels.
Remnant kidney tissue MDA, GSH, SOD, catalase and
NO levels are summarized in Table 2. In remnant kidney,
N group MDA and catalase levels were significantly higher
than in the S and IN groups. IN group NO and GSH levels
were higher than in the N group. N group Cu-Zn SOD
levels were lower than in the S and IN groups.
Discussion
Cytokine production reflects the degree of tissue trauma;
cytokine release is lowest with the least invasive and trau-
matic procedures. Increased plasma IL-6 levels are observed
as a result of tissue damage and high stress conditions.23,24
It has been suggested that elevated endogenous IL-6 could
attenuate renal injury, dysfunction and inflammation after
ischaemia-reperfusion injury.25 It has been documented
that high IL-6 level is closely associated with duration of
hospitalization after surgery.23 Increased plasma IL-6 levels
were observed as a result of tissue damage and high stress
conditions. Czeslick et al suggested that iloprost may down-
regulate the intracellular expression of IL-6 and tumour ne-
crosis factor-α in human monocytes.26 It has been shown
that iloprost reduces oxidative damage in various tissues.4,27
Iloprost pretreatment reduces IL-6 and lipid peroxidation
level, which are increased after unilateral nephrectomy.
Compensatory hypertrophy of the remaining kidney
occurs after unilateral nephrectomy. The remaining kid-
ney adapts by a compensatory increase in the glomerular
filtration rate and renal mass.28 Increased renal blood
flow and glomerular pressure due to unilateral nephrec-
tomy are suggested as the mechanical triggers of compensa-
tory hypertrophy of the remaining kidney.29 Flow-mediated
renal vasodilatation in the remnant kidney that occurs
after unilateral nephrectomy is suggested to be NO depen-
dent.6 NO and prostacyclin are released from endothelium.
Endothelial functions play a key role in functional adap-
tation mechanisms after nephrectomy. Iloprost may pro-
tect the endothelium by reducing lipid peroxidation and
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Table 1. Urea, creatinine, interleukin (IL)-6, malondialdehyde (MDA), glutathione (GSH) and Cu-Zn superoxide dismutase (SOD) levels
S (n= 12) N (n= 12) IN (n= 12)
Serum urea (mg/dL) 45.00 ± 7.00 46.67 ± 5.03 45.34 ± 5.24
Serum creatinine (mg/dL) 0.53 ± 0.05 0.60 ± 0.001 0.55 ± 0.06
Plasma IL-6 (pg/mL) 749.50 ± 31.65 834.00 ± 41.55* 808.50 ± 33.17†‡§
Plasma MDA (nmol/mg protein) 1.42 ± 0.16 2.09 ± 0.21* 1.58 ± 0.23*§
Intraerythrocytic GSH (g/mg protein) 3.57 ± 0.29 2.82 ± 0.15* 3.09 ± 0.25†§
Intraerythrocytic Cu-Zn SOD (U/mg protein) 24.23 ± 1.28 24.01 ± 1.61
*p < 0.001; †p < 0.05; ‡significant different between S and IN groups (p < 0.05); §significant difference between N and IN groups (p < 0.05);
significant difference between S and N groups (p< 0.05). S = sham group; N = unilateral nephrectomized group; IN = an hour before unilateral
nephrectomy iloprost administered group.
Table 2. Remnant kidney tissue malondialdehyde (MDA), glutathione (GSH), Cu-Zn superoxide dismutase (SOD), catalase (CAT)
and nitric oxide (NO) levels
S (n= 12) N (n= 12) IN (n= 12)
MDA (nmol/mg protein) 0.31 ± 0.05 0.48 ± 0.07*‡ 0.29 ± 0.06*§
GSH (g/mg protein) 30.09 ± 6.50 22.23 ± 7.39 32.09 ± 6.50†§
SOD (U/mg protein) 0.97 ± 0.11 0.79 ± 0.12†‡ 1.04 ± 0.15†§
CAT (U/mg protein) 18.78 ± 3.96 30.37 ± 4.83*‡ 15.10 ± 3.38*§
NO (µmol/g wet tissue) 0.145 ± 0.01 0.156 ± 0.01 0.175 ± 0.01†§
*p< 0.001; †p< 0.05; ‡significant difference between S and N groups (p< 0.05); §significant difference between N and IN groups (p< 0.05). There
was no significant difference between S and IN groups.
support antioxidant response.30 NO levels in remnant
kidney increased after unilateral nephrectomy and ilo-
prost pretreatment in our study. It has been demonstrated
that NO release can be evoked by a stable analogue of
prostacyclin.31 The role of NO seems to be controversial
because in some models of inflammation, it has been
shown that tissue dysfunction or injury could occur after
inhibition of NO.32 However, high production of NO is
suggested to be a cause of tissue injury, perhaps through the
generation of potent radicals. Studies are not in consen-
sus as to whether NO is cytotoxic or cytoprotective. It may
act both as a cytotoxic agent and a cytoprotective agent,
the main determinants being its concentration and the
environment.33,34
Oxidative stress and IL-6 levels increase due to anaes-
thesia and surgery and cause organ damage during sur-
gery and in the short-term postoperative period. Iloprost
pretreatment before unilateral nephrectomy could reduce
tissue damage and support the healing process by reduc-
ing oxidative stress and inflammation. According to this
data, we speculate that iloprost pretreatment could reduce
complications during and after surgery in high risk patients
who have diabetes, end-stage renal disease or renal tumours,
but further studies are needed to clarify this hypothesis.
By doing this current study, we showed that iloprost pre-
treatment before unilateral nephrectomy reduces oxidative
stress, forming a sound basis for our further studies.
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